Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
ModeX nets up to $168M in BARDA bucks to cook up new antibodies
ModeX has snagged a $168 million contract from BARDA, including $59 million upfront to finance a phase 1 trial for a novel COVID-19 antibody.
Max Bayer
Sep 29, 2023 10:43am
Adlai bags $57.5M IPO to test ex-Novartis cancer drug in phase 3
Sep 29, 2023 10:00am
Sponsored
Improving the Drug Development Process with Organ-Chips
Sep 25, 2023 8:00am
Madrigal COO departs days after new CEO starts—Chutes & Ladders
Sep 29, 2023 9:30am
Sponsored
Uncover the Rare Disease Patient Journey
Sep 25, 2023 8:00am
PTC deepens layoffs as DMD drug faces loss of EU authorization
Sep 29, 2023 8:51am
